MYRIAD GENETICS INC — Director's Dealing 2021

Mar 25, 2021

SEC Form 4/A — Form 4/A

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-12-04

Reporting Person: Skovronsky Daniel (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25041	Direct

Footnotes

F1: This filing is deemed to amend the Form 4, which was filed on December 7, 2020, in error, on behalf of Mr. Skovronsky, showing a grant of 15,889 restricted stock units on December 4, 2020, to reflect that Mr. Skovronsky did not receive such grant of restricted stock units.